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A B S T R A C T
This is the protocol for a review and there is no abstract. The objectives are as follows:
To evaluate the effectiveness of de-escalation techniques for staff and service users in the management of non-psychosis-induced
aggression in adults.
B A C K G R O U N D
Description of the condition
Aggression is any behaviour directed toward another individ-
ual that is carried out with the immediate intent to cause harm
(Anderson 2002). This may be communicated verbally or may
manifest in a range of behaviours causing physical or psychological
harm towards the self or others, or damage to the environment
(NICE 2015a).There is a substantial body of literature on the ori-
gins of aggressive behaviour and theories to account for the causes
of aggression. For example, the general aggression model proposes
that specific context and person-centred factors are mediated by
variables such as cognition, affect and arousal in the manifestation
of aggression (Anderson 2002). There is not scope within this re-
view to fully explore all of the relevant literature on the aetiology
of aggressive behaviour and therefore we will focus on the man-
agement of these behaviours within the broad context of health
services.
Aggression can occur in many settings, including inpatient set-
tings, emergency settings (NICE 2015a), and in communities
served by emergency services such as police or paramedics (Hester
2009). Aggression that is left untreated may escalate into violence
involving risks to the aggressor and those around them such as fam-
ily and healthcare professionals (Bourget 2002; Maguire 2007).
Workplace violence affects every country and healthcare setting,
with reports estimating that 4%of the global employee population
have experienced physical violence, and nurses are at three times
greater risk of violence than any other profession (Di Martino
2003). A large international review of 424 studies reported an
incidence rate of over 32% for violence in psychiatric hospitals,
but a greater risk of violence in acute healthcare settings (Bowers
2011). In the UK, physical assaults against National Health Ser-
vice (NHS) staff are estimated at 67,864 incidents per annum,
with 67% of those occurring in mental health settings, 28% in
acute hospitals and the remainder in ambulance and primary care
settings (NHS Protect 2015). In England alone 14% of NHS staff
reported having experienced physical violence from service users,
relatives or the public (NHS 2014). Violence is also prevalent in
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community settings where around half of care workers experience
verbal abuse and over a third experience physical abuse (NICE
2015b). Aggressive and violent behaviour may have a significant
impact on staff with an estimated 26%, 11% and 6% of incidents
respectively relating to mild, moderate or severe injury (Bowers
2011). Verbal aggression toward staff is common and may lead to
poor performance and functioning (Stone 2010; Uzun 2003); and
low morale (Bowers 2009; Sprigg 2007). Increased exposure to
violence from service users is correlated with increased stress and
reduced job satisfaction in social care and social work staff (Harris
2012).
Aggression may be associated with intrinsic factors such as recog-
nised mental health issues (Fazel 2006), including, for the pur-
poses of this review, substance misuse, intellectual disability and
other mental health issues (excluding psychosis), and extrinsic fac-
tors such as social and environmental conditions. Certain condi-
tions also place individuals at increased risk of an episode of acute
aggression such as head injury; Huntingdon’s Disease (Johnson
2011); learning disability (Taylor 2005); and alcohol or substance
misuse, or both (Roizen 1997; Snowden 2001). The multi-facto-
rial origins of aggression mean that it can apply to a wide popula-
tion.
Health care professionals are required to use strategies for man-
aging incidents of aggression and violence that are proportion-
ate to the potential or immediate risk posed to self and oth-
ers, commensurate with the principles of least restrictive prac-
tice (DoH 2005). Interventional measures, such as physical re-
straint, rapid tranquillisation (for example, intramuscular injec-
tions) and seclusion, are used tomanage aggression (NICE 2015a).
The use of specialist nursing care, such as seclusion, is recom-
mended only when the risk to self and others cannot be safely
managed in communal or private environments, as containment is
often aversive and unpleasant for both service users (Whittington
2009) and staff (Olofsson 1995). Seclusion suites used for physical
containment are commonly found in Psychiatric Intensive Care
Units (PICUs) to manage a range of circumstances, including dis-
ruptive behaviour (Oldham 1983), acute psychiatric symptoms
(Morrison 1991), verbal and physical aggression (Mason 2001;
Sullivan 2004), damage to property (Ahmed 2001), self harm
(O’Brien 2004), and risk of absconding (Morrison 1997). Use of
seclusion varies both within (Crenshaw 1995) and between coun-
tries (Bowers 2007), though rates are poorly reported in terms of
specific context (Bowers 2000). However, as these invasive meth-
ods are associated with increased risk of injury to both service users
(Hollins 2010) and staff (Farrell 2005), they are employed only
when de-escalation is unsuccessful.
To minimise the potential for harm, an episode of escalating ag-
gression needs to be promptly defused using de-escalation tech-
niques as the first resort intervention measure (NICE 2015a).
Description of the intervention
The National Institute for Health and Care Excellence (NICE)
guideline on management of violence in healthcare settings de-
scribes de-escalation as “talking with an angry or agitated service
user in such a way that violence is averted and the person regains
a sense of calm and self-control“ (NICE 2015a, p 30). De-escala-
tion, sometimes referred to as ’defusing’ or ’talk-down’, is a complex
range of verbal and nonverbal communication skills used by staff
in a range of settings to prevent escalation of aggressive behaviour
(CRAG 1996). Recognised de-escalation techniques include ver-
bal strategies, such as maintaining a calm tone of voice and not
shouting or verbally threatening the person; and non-verbal tech-
niques, including an awareness of self, body stance, eye contact,
and personal safety (Cowin 2003; Johnson 2011). It has been sug-
gested that verbal and non-verbal communication skills may help
to redirect someone to a “calmer personal space” (Cowin 2003).
Although de-escalation is recommended and widely used for the
management of aggression, there is little literature on specific tech-
niques and efficacy (Richmond 2012; Robertson 2012). The con-
sensus statement from the American Association for Emergency
Psychiatry Project BETA De-escalationWorkgroup estimates that
effective de-escalation of an aggressive episode, in order to return
the agitated person to a calm state, should take approximately 5
to 10 minutes. De-escalation, therefore, is intended to ameliorate
the immediate aggressive episode and is not associated with longer
term benefits (Richmond 2012).
De-escalation is recommended as an early intervention in theman-
agement of aggression in order to prevent escalation to the cri-
sis phase (NICE 2015a). Potential benefits to service users (such
as improved health and well-being) from approaches that avoid
physical intervention are relativelywell established (Paterson1997;
Robertson 2012).
Staff training in de-escalation techniques is an important feature
of aggression management programmes (Farrell 2005). Benefits
for service users and staff are currently unclear, with reported im-
provements in staff morale and confidence (Gournay 2001; Nau
2009), but little impact on the frequency of aggressive incidents
(Bowers 2006). In North America there are four widely used staff
training programmes for the collective management of aggressive
behaviour: The Mandt System (Mandt 1998); Nonviolent Crises
Intervention (CPI 2005); Professional Assault Response Training
(Smith 2004); and Therapeutic Options (Partie 2001), but these
approaches are less commonly used elsewhere.
De-escalationmay be deployed in a range of settings, including ac-
cident and emergency (A&E), psychiatric hospitals, learning dis-
ability services, and in restraint or containment settings used by the
police force where it may be embedded in conflict resolution tech-
niques (NHSBSA 2013). The application of de-escalation tech-
niques may vary by specific context and population, for example
when working with people with a cognitive impairment, such as
dementia. In the UK, NICE guidelines for the management of
people with dementia recommend that health and care staff receive
specific training in the anticipation of challenging behaviour and
2De-escalation techniques for managing aggression (Protocol)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
managing of violence using de-escalation techniques and restraint
methods (NICE 2015b).
How the intervention might work
In clinical settings ‘The Assault Cycle’ is a theoretical model, which
describes five phases in aggressive behaviour: the trigger phase, es-
calation phase, crisis phase, recovery phase, and depression phase
(Kaplan 1983; Leadbetter 1995). De-escalation aims to arrest the
progress of the assault cycle during the escalation phase. Some
of the skills and techniques used to arrest the assault cycle, in-
clude the avoidance of confrontation, attitude and use of language,
awareness of personal space, and posture. These components are
described in the ACT (Assessment, Communication and Tactics)
cyclical model by Dix 2008. There are a number of competing
theoretical approaches to de-escalation but the key recommended
components are: recognising the signs of escalating anger; and ap-
proaching the person in a calm manner (NICE 2015a). These
techniques may help de-escalate potentially aggressive situations
by establishing a positive relationship between staff and aggres-
sor in the management of appropriate behavioural expectations
(Levenson 2004). De-escalation techniques are recommended as
a frontline response for defusing aggressive or agitated behaviour,
but there is no universally accepted model and the core skill set is
poorly documented (Robertson 2012).
Why it is important to do this review
In the UK, the Winterbourne Enquiry into the abuse of patients
in learning disability services, including inappropriate use of phys-
ical interventions and restraints, resulted in increased pressure on
all mental health and learning disability care settings to find safe
alternatives to the use of physical intervention (CQC 2011). Evi-
dence of effectiveness of alternative methods of managing aggres-
sive behaviour, other than with physical intervention such as re-
straint and seclusion, is unclear. Muralidharan 2006 suggests that
evidence is inconclusive due to lack of high quality studies and
Gaskin 2007 argues for strong evidence in favour of alternative
approaches on the basis of all available evidence. Although de-es-
calation techniques are recommended by a number of guidelines
(for example, those of NICE or The American Psychological As-
sociation (APA)) for managing aggressive behaviour, there is no
standard approach for the technique and little research has been
published comparing the effectiveness of different methods, or the
effectiveness of de-escalation training (Paterson 1997).
Improved staff morale and confidence have been reported as po-
tential benefits of de-escalation training (Cowin 2003), but ev-
idence of impact on staff outcomes is currently unclear. Alter-
natives to physical intervention are associated with reduced risk
of injury for both staff and patients (Hill 1987; Johnson 2012),
but the relative effectiveness of different approaches to de-escala-
tion in terms of both staff and patient outcomes is also unclear.
Therefore, there is a need to systematically review the evidence
for the effectiveness of de-escalation in managing aggression. A
Cochrane review that aims to evaluate de-escalation techniques
for psychosis-induced aggression is currently in preparation (Rao
2012). We propose a companion and complementary review that
will evaluate techniques for people without psychosis.
O B J E C T I V E S
To evaluate the effectiveness of de-escalation techniques for staff
and service users in the management of non-psychosis-induced
aggression in adults.
M E T H O D S
Criteria for considering studies for this review
Types of studies
Randomised controlled trials (RCTs) and quasi-RCTs (defined as
trials where participants are allocated to study groups using, for
example, date of birth or alternate allocation).
Types of participants
Adults (≥ 18 years) in any care setting, who use threatening or
aggressive behaviour.
Excluded
Service users with a diagnosis of schizophrenia spectrum disorder
(APA 2013). This will exclude people with psychosis-induced ag-
gression, which is covered by a separate Cochrane Review (Rao
2012).
Types of interventions
Experimental intervention
Any de-escalation technique, as defined above.
Control intervention
Standard practice (including rapid tranquillisation, physical inter-
vention, seclusion) or an alternate de-escalation technique.
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Types of outcome measures
Effects of de-escalation may range from a few minutes to several
hours. The distinction between successful de-escalation of the pri-
mary aggressive event and subsequent events may be complex,
and therefore we will collect outcome data at a range of follow-up
points that will best reflect the available evidence from included
studies.
Primary outcomes
1. Frequency of aggression-related serious untoward incidents
(including mortality), leading to physical restraint or seclusion,
or both: recorded in staff reports or routinely collected data.
2. Frequency of aggression-related injuries to staff: recorded in
staff reports or routinely collected data such as untoward
incident forms.
Secondary outcomes
1. Length of stay in seclusion: recorded in staff reports or
routinely collected data such as untoward incident forms.
2. Validated (psychometric publication of scale properties;
Streiner 2014; Zumbo 2007) generic or condition-specific
quality of life scales (for example, Short Form 36 Health Survey
(SF-36; Ware 1992) or De-escalating Aggressive Behaviour Scale
(DABS; Nau 2009b)), or both.
3. Staff absenteeism: based on administrative data.
4. Costs of care; cost-benefit, cost-effectiveness: for example,
monetary benefit or quality-adjusted life years (QALYs).
We will prioritise outcomes based on formally or routinely col-
lected data such as untoward incident or adverse event forms.
Search methods for identification of studies
Electronic searches
We will search Ovid MEDLINE using the strategy in Appendix
1, and adapt it for use in other sources. We will not apply any
language restrictions or time period limitations to the searches.
We will search the following databases.
1. Cochrane Central Register of Controlled Trials
(CENTRAL; current issue; The Cochrane Library), which
includes the specialised register of the Cochrane Developmental,
Psychosocial and Learning Problems Group.
2. Ovid MEDLINE (1946 to current).
3. EMBASE (1974 to current; Ovid).
4. PsycINFO (1806 to current; Ovid).
5. CINAHL (1937 to current; EBSCOhost).
6. Science Citation Index Expanded (SCI-Expanded; 1970 to
current; Web of Science).
7. Social Sciences Citation Index (SSCI; 1970 to current; Web
of Science).
8. Conference Proceedings Citation Index - Science (CPCI-S;
1990 to current; Web of Science).
9. SciELO Citation Index (Web of Science; 1970 to current;
Web of Science).
10. Academic Search Complete (1990 to current; EBSCOhost).
11. International Bibliography of the Social Sciences (1951 to
current; Proquest).
12. British Education Index (1974 to current; EBSCOhost).
13. ERIC (1996 to current; EBSCOhost).
14. Criminal Justice Abstracts (all available years; EBSCOhost).
15. Cochrane Database of Systematic Reviews (CDSR; current
issue; The Cochrane Library).
16. Database of Abstracts of Reviews of Effects (DARE; current
issue; The Cochrane Library).
17. The Campbell Collaboration Library of Systematic Reviews
(campbellcollaboration.org/lib/; current issue).
18. World Health Organisation International Clinical Trials
Registry Platform (ICTRP; apps.who.int/trialsearch; all available
years).
19. ClinicalTrials.gov (clinicaltrials.gov; all available years).
20. ISRCTN (ISRCTN.com; all available years).
21. OpenGrey (opengrey.eu; all available years).
Searching other resources
Wewill examine the reference lists of relevant studies and reviews to
find any additional trials not identified by the electronic searches.
We will contact authors of identified trials and authorities in the
field in order to locate other published and unpublished studies
Data collection and analysis
Selection of studies
Two authors (PJ, SS) will independently assess the titles and ab-
stracts of all retrieved trials. The same authors will then examine
the full text of papers identified as relevant to determine inclusion
in the review. We will resolve disagreements about eligibility and
inclusion by discussion until consensus is reached.
Data extraction and management
SS and PJ will independently read and extract data from the in-
cluded studies using a form based on the predefined outcomemea-
sures. We will contact study authors for information on missing
data or further information about the trial. We will systematically
record information on study design, participants, intervention,
outcomes, methods, results, and study withdrawals in the ’Charac-
teristics of included studies’ tables. Disagreements will be resolved
by discussion until consensus is reached.
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Assessment of risk of bias in included studies
SS and PJ will independently assess the quality of each included
study using the risk of bias criteria described in theCochrane Hand-
book for Systematic Reviews of Interventions (Higgins 2011a). Risk
of bias will be rated as high, low or unclear across the domains be-
low. We will resolve disagreements by discussion until a consensus
is reached. The results will be tabulated in a ’Risk of bias’ table.
Random sequence generation
1. Low risk of bias: adequate sequence generation using, for
example, random number tables, coin toss, drawing lots, dice
throw.
2. High risk of bias: inadequate sequence generation using a
non-random method of allocation (for example, date of birth,
hospital admission date or clinic number).
3. Unclear risk of bias: information on sequence generation
not given or unclear.
Allocation concealment
1. Low risk of bias: adequate concealment (for example,
central allocation method such as telephone or web-based
randomisation, or sealed opaque envelopes).
2. High risk of bias: inadequate concealment of allocation (for
example, open list of numbers, envelopes without concealed
contents, or dates of birth).
3. Unclear risk of bias: information on allocation of
randomisation not given or unclear.
Blinding of participants and personnel
1. Low risk of bias: adequate where study participants and
personnel are blinded to allocated interventions or where authors
judge that study outcomes will not be influenced by lack of
blinding.
2. High risk of bias: inadequate where study outcomes are
likely to be influenced by lack of blinding or incomplete
blinding.
3. Unclear risk of bias: information on blinding not given or
unclear.
Blinding of outcome assessment
1. Low risk of bias: adequate where study participants and
personnel are blinded to outcome assessment or where authors
judge that outcome measures will not be influenced by lack of
blinding.
2. High risk of bias: inadequate where measurement of
outcomes is not blinded and may be influenced by lack of
blinding.
3. Unclear risk of bias: information on blinding of outcome
assessment not given or unclear.
Incomplete outcome data
1. Low risk of bias: adequate (for example, no missing data,
missing data unrelated to true outcome (for example, survival
data) or balanced across study groups; reasons for missing data
similar across groups; appropriate imputation (for example,
uncertainty taken into account)).
2. High risk of bias: inadequate (for example, missing data
may be related to true outcome (missing not at random); reasons
for missing data or missing proportions differ between groups;
inappropriate imputation (for example, high proportion of data
imputed using last observation carried forward)).
3. Unclear risk of bias: information on incomplete outcome
data not given or unclear.
Selective reporting
1. Low risk of bias: adequate (for example, it is clear that all
pre-specified or expected study outcomes have been reported
consistently).
2. High risk of bias: inadequate (for example, not all pre-
specified outcomes reported, primary outcomes reported that
were not pre-specified, or outcome reported using methods not
pre-specified).
3. Unclear risk of bias: information on outcome reporting not
given or unclear.
Other bias
1. Low risk of bias: adequate where no other sources of bias
are identified.
2. High risk of bias: inadequate where other important sources
of bias are identified such as an inappropriate study design.
3. Unclear risk of bias: insufficient information on which to
evaluate risk of other bias.
Measures of treatment effect
Continuous data
We will estimate the intervention effect using the mean difference
(MD) and its 95% confidence interval (CI). If standard deviations
(SD) are not reported but other measures of variance around mean
differences, such as standard error, CIs, or P value are reported,
we will calculate these according to Section 7.3 in the Cochrane
Handbook for Systematic Reviews of Interventions (Higgins 2011a).
In this review it is likely that different scalesmay be used tomeasure
the same outcome (for example, level of aggression). In this case,
we will use the standardised mean difference (SMD) and its 95%
CI, ensuring a consistent direction of effect by reversing scaling
where necessary, supported by a statement in the text on direction
of interpretation. Where studies use the same outcome measure,
we will use the mean difference (MD).
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Binary data
For dichotomous data, we will use risk ratios (RR) with 95% CIs.
Unit of analysis issues
Cross-over trials
We will only use data from the first pre-cross-over phase to min-
imise potential bias from carry-over effects.
Cluster-randomised trials
These will be analysed in accordance with methods described in
Section 16.3 of the Cochrane Handbook for Systematic Reviews of
Interventions (Higgins 2011a), using the average cluster size and
an estimate of the intraclass correlation coefficient (ICC) to adjust
sample sizes to the ’effective sample size’. Where an estimate of the
ICC is not available from the trial we will use an estimate from a
similar trial or a trial with a similar population. We will combine
single RCTs with cluster-RCTs if the designs and interventions are
considered sufficiently similar and the effect of the intervention is
unlikely to be influenced by the method of randomisation.
Multiple arm trials
For trials with more than two arms, we will describe all study
groups in the ’Characteristics of included studies’ table, but wewill
only include in the analysis the intervention groups that meet our
review criteria. Where the variance of the difference between the
intervention and the comparator is not reported, we will calculate
this from the variances of all trial arms.
Where a study compares multiple relevant interventions groups
to one eligible control group, we will divide the sample size for
the shared comparator group evenly, in order to prevent the same
participants from being included twice. Where a study compares
one eligible intervention group to two or more distinct but eligi-
ble control groups, we will combine the groups to create a single
pairwise control comparison (Higgins 2011b). For dichotomous
outcomes, both the sample sizes and the numbers of people with
events will be summed across groups; and for continuous or time-
to-event outcomes, means and SDs will be combined using meth-
ods described in the Cochrane Handbook for Systematic Reviews
of Interventions (Higgins 2011a). If this prevents identification of
potential heterogeneity, we will compare each group separately
as part of subgroup analyses. Decisions made concerning unit of
analysis issues will be reported in the review.
Dealing with missing data
We will contact all authors of included studies to provide any un-
reported data such as missing outcomes, missing data, means or
SDs. We will note differential dropout between study groups and
note reasons for withdrawal. Where a particular outcome includes
substantial loss to follow-up (50%), we will report this in the text
and mark the data with an asterisk. We will also note differential
missing data and reasons for missing data, where reported. We
will use available cases for data analysis and we will not impute
missing data. Where trials include analyses based on the imputa-
tion of missing values, we will include data at low risk of bias and
report data separately for those at higher risk of bias in the text of
the review. Multiple imputation methods that include sensitivity
analyses, pre-specified in published protocols, are considered at
low risk of bias (Gewandter 2014; Little 2012).
Where missing data are related to the outcome it is not considered
appropriate to impute data using carry-forward methods such as
last observation carried forward or baseline observation carried
forward; for example, if a participant dies due to an intervention-
related adverse event shortly after randomisation, it would not be
appropriate to carry over the baseline data in order to complete
missing data (Gewandter 2014).Where studies report per protocol
data (that is, only those who completed the study), we will contact
the authors for unreported data on all study participants, including
those lost to follow-up. Missing data will be described in the ’Risk
of Bias’ table and its influence on study outcomes discussed in the
text. If there are sufficient trials, we will use sensitivity analyses
to determine the resistance of our results to the effects of missing
data (see Sensitivity analysis).
Assessment of heterogeneity
In this review, it is likely that there will be considerable variability
between studies in terms of the specification of the intervention,
the study design and the outcomes. The variability may be a conse-
quence of clinical variation in the population or the intervention,
differences in study quality, or random differences. We will assess
potential sources of variability between studies in the following
ways.
1. Clinical variability: we will compare the distribution of
participants, interventions, and outcomes across the included
studies. In particular, we will look at the distribution of trials
that only include people with cognitive impairment (such as
dementia), as potential sources of variability. We will discuss and
agree potential clinical heterogeneity by consensus.
2. Methodological variability: we will compare study designs
and study quality using risk of bias criteria.
3. Statistical heterogeneity (where variability in the effects of
interventions is greater than expected by chance alone): we will
evaluate the statistical significance of heterogeneity using the
Chi² test (P ≤ 0.10 significant). However, this test may be
unreliable, lacking power to detect important heterogeneity with
few or small studies and the potential to detect clinically
insignificant heterogeneity with large numbers of studies. It is
also possible for trials to show large consistent effects in the face
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of significant heterogeneity. Therefore, in addition to assessing
the strength of evidence for heterogeneity using the Chi² test as
above, we will also quantify the magnitude of heterogeneity
using the ² (random-effects model only), and I² statistics with
the following interpretation thresholds, based on
recommendations in Section 9.5 of the Cochrane Handbook for
Systematic Reviews of Interventions (Higgins 2011a):
i) 0% to 40%: might not be important;
ii) 30% to 60%: may represent moderate heterogeneity;
iii) 50% to 90%: may represent substantial heterogeneity;
and
iv) 75% to 100%: considerable heterogeneity.
Assessment of reporting biases
We will compare the results of data from published and unpub-
lished studies as a direct test of publication bias. If there are a
sufficient number of studies (approximately 10 or more), we will
explore potential bias arising from small study effects using Eg-
ger’s method, to test for asymmetry in funnel plots (Egger 1997).
If smaller studies show larger intervention effects compared to
larger studies, we will evaluate potential causes (for example, poor
methodological quality; differences in populations or interven-
tions) and report studies at high risk of bias in the text of the re-
view. If small study effects are detected, we will explore if this is
a genuine finding due to heterogeneity (small studies give larger
effects because they differ from large ones in some aspect that
modifies the effect of the intervention) or if this is because of poor
quality, publication bias etc.
Data synthesis
We will undertake separate meta-analyses for the comparisons of
interest in this review (de-escalation versus physical intervention;
de-escalation method X versus de-escalation method Y).
Studies will be included in meta-analyses where the study designs,
interventions and outcomes are similar. Where substantial het-
erogeneity (> 50%; Higgins 2011a) is identified we will report
outcomes in the text, giving direction and size of the effect along
with strength of the evidence (risk of bias). It is likely that in-
cluded studies will vary in their population, design and outcomes,
and therefore data synthesis using meta-analysis with a random-
effects model would be most appropriate. However, where there
are few studies or the effects of interventions across studies are
not randomly distributed (for example, with publication bias), the
random-effects model estimates may be unreliable or biased. It is
likely that this review will only include a small number of low-
powered studies, where meta-analysis with a fixed-effect model
would give more reliable estimates. To resolve the uncertainty over
model choice we will (a) only pool data using meta-analysis where
studies appear sufficiently similar (for example, all dementia pop-
ulations or all learning disability), and (b) compare pooled data
estimates from both a random-effects model and a fixed-effect
model, reporting both in the text. We will report the mean effect
estimate and the CI around the estimate for both models. We will
synthesise and report dichotomous and continuous data separately
for a given outcome, should the need arise. Where end-of-study
point estimates and change from baseline scores are reported we
will analyse these separately. We will perform the analyses using
Review Manager (RevMan) Version 5 (Review Manager 2014)
The results of analyses of head-to-head comparisons of de-esca-
lation techniques will be interpreted tentatively in the absence of
data from trials comparing de-escalation techniques versus physi-
cal intervention.
Summary of Findings
Wewill report the primary outcomes, and the following secondary
outcomes, in a ’Summary of findings’ table for each intervention
comparison: frequency of aggression-related serious untoward in-
cidents, frequency of aggression-related injuries to staff, and val-
idated quality of life scales. The table will also report the quality
of evidence for each outcome using the Grading of Recommen-
dations Assessment, Development and Evaluation (GRADE) ap-
proach, which considers within-study risk of bias, directness of
evidence, heterogeneity, precision of effect estimates, and risks of
publication bias (GRADE 2004). We will tabulate the summary
of findings using GRADEpro software (GRADEPro GDT 2015).
The GRADE Working Group grades of evidence are as follows:
1. High quality: further research is very unlikely to change
confidence in the estimate of effect;
2. Moderate quality: further research is likely to have an
important impact on confidence in the estimate of effect and
may change the estimate;
3. Low quality: further research is very likely to have an
important impact on confidence in the estimate of effect and is
likely to change the estimate; and
4. Very low quality: we are very uncertain about the estimate.
Subgroup analysis and investigation of heterogeneity
Subgroup analyses
Where there are a sufficient number of trials (≥ 10; Section9.6.5.1,
Higgins 2011a), we will conduct subgroup analyses by:
1. Staff training (trained versus untrained staff ).
Investigation of heterogeneity
We will manage potential sources of heterogeneity as follows:
1. Check data integrity, including measures of effect and units
of analysis;
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2. Explore the impact of subgroups (for example, small versus
large studies); and
3. Exclude outliers where there is a clear reason for exclusion
such as markedly different intervention effect estimates or clear
population differences (for example, dementia or learning
disability). We will visually inspect forest plots and iteratively
remove outlying studies to determine whether homogeneity is
restored.
We will fully discuss and report our decisions in the review.
Sensitivity analysis
We will perform sensitivity analyses for missing data, and for risk
of bias based on random sequence generation, blinding of partic-
ipants and incomplete outcome data by including and excluding
studies at high risk of bias and comparing the results.
Although little data are available on the measurement of out-
comes following de-escalation of aggressive episodes, it is plausible
that outcomes may vary by duration of follow-up. Therefore, we
will explore potential heterogeneity between studies according to
length of follow-up (that is, all studies versus excluding the longest
studies).
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A P P E N D I C E S
Appendix 1. Ovid MEDLINE
Lines 29 to 39 form the Cochrane highly sensitive search strategy for identifying randomised trials in Medline (Lefebvre 2011).
1 Aggression/
2 Psychomotor agitation/
3 Agonistic Behavior/
4 Violence/
5 Workplace Violence/
6 exp Anger/
7 Hostility/
8 (aggress$ or agitat$ or agonistic or anger or angry or assault$ or hostil$ or rage or threat$ or violen$).tw.
9 ((abusive or challenging or disturbed or disruptive) adj1 behav$).tw.
10 or/1-9
11 Risk management/
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12 Behavior control/
13 Safety management/
14 Security measures/
15 (de-escalat$ or deescalat$ or non-escalat$ or nonescalat$ or defus$ or de-fus$).tw.
16 (non$ adj (authorit$ or coerc$ or co-erc$ or combativ$ or confrontation$ or physical or provocative or violen$)).tw.
17 (non$ adj (drug$ or pharma$)).tw.
18 ((alternative$ or avoid$ or reduc$ or without$) adj3 (seclusion or restrain$)).tw.
19 (talkdown or talk-down or one to one).tw.
20 (limit$ adj1 setting).tw.
21 Negotiating/
22 negotiat$.tw.
23 ((verbal$ or nonverbal$ or non-verbal$) adj3 (communicat$ or intervention$ or strateg$ or method$ or technique$)).tw.
24 Crisis intervention/
25 (cris#s adj3 (intervention$ or manag$ or resol$ or respon$ or team$)).tw.
26 (conflict adj3 (avoid$ or manage$ or prevent$ or resol$)).tw.
27 (calm or calming).tw.
28 or/11-27
29 randomized controlled trial.pt.
30 controlled clinical trial.pt.
31 randomi#ed.ab.
32 placebo$.ab.
33 drug therapy.fs.
34 randomly.ab.
35 trial.ab.
36 groups.ab.
37 or/29-36
38 exp animals/ not humans.sh.
39 37 not 38
40 10 and 28 and 39
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